State Of Wisconsin Investment Board Point Biopharma Global Inc. Transaction History

State Of Wisconsin Investment Board

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$6.67 - $9.71 $8,584 - $12,496	-1,287 Reduced 2.3%	54,575 $364,000
Q2 2023 Aug 14, 2023	SELL	$6.86 - $10.86 $20,449 - $32,373	-2,981 Reduced 5.07%	55,862 $506,000
Q1 2023 May 15, 2023	SELL	$6.78 - $8.1 $44,361 - $52,998	-6,543 Reduced 10.01%	58,843 $427,000
Q4 2022 Feb 14, 2023	BUY	$5.72 - $9.78 $107,976 - $184,617	18,877 Added 40.59%	65,386 $476,000
Q3 2022 Nov 14, 2022	BUY	$7.24 - $10.31 $49,420 - $70,376	6,826 Added 17.2%	46,509 $360,000
Q2 2022 Aug 15, 2022	BUY	$5.6 - $9.5 $54,784 - $92,938	9,783 Added 32.72%	39,683 $270,000
Q1 2022 May 13, 2022	BUY	$5.46 - $8.13 $163,254 - $243,087	29,900 New	29,900 $238,000

20K

Ticker PNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 104,025,000
Description
POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.